Canada · Delayed Price · Currency is CAD Alzai Health Statistics
Total Valuation
Alzai Health has a market cap or net worth of CAD 20.09 million. The enterprise value is 18.77 million.
| Market Cap | 20.09M |
| Enterprise Value | 18.77M |
Important Dates
The next estimated earnings date is Thursday, November 26, 2026.
| Earnings Date | Nov 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Alzai Health has 64.80 million shares outstanding.
| Current Share Class | 64.80M |
| Shares Outstanding | 64.80M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | +12.03% |
| Owned by Insiders (%) | 13.73% |
| Owned by Institutions (%) | n/a |
| Float | 55.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 290.74 |
| PB Ratio | 13.19 |
| P/TBV Ratio | 13.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 271.64 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.62, with a Debt / Equity ratio of 0.39.
| Current Ratio | 4.62 |
| Quick Ratio | 4.54 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.16 |
| Interest Coverage | -42.42 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -189.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 37.86 |
| Average Volume (20 Days) | 56,737 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Alzai Health had revenue of CAD 69,087 and -4.13 million in losses. Loss per share was -0.08.
| Revenue | 69,087 |
| Gross Profit | -480,367 |
| Operating Income | -4.00M |
| Pretax Income | -4.13M |
| Net Income | -4.13M |
| EBITDA | -4.00M |
| EBIT | -4.00M |
| Loss Per Share | -0.08 |
Balance Sheet
The company has 1.91 million in cash and 587,805 in debt, with a net cash position of 1.32 million or 0.02 per share.
| Cash & Cash Equivalents | 1.91M |
| Total Debt | 587,805 |
| Net Cash | 1.32M |
| Net Cash Per Share | 0.02 |
| Equity (Book Value) | 1.52M |
| Book Value Per Share | 0.02 |
| Working Capital | 1.67M |
Cash Flow
In the last 12 months, operating cash flow was -3.73 million and capital expenditures -17,806, giving a free cash flow of -3.75 million.
| Operating Cash Flow | -3.73M |
| Capital Expenditures | -17,806 |
| Depreciation & Amortization | -213 |
| Net Borrowing | 860,158 |
| Free Cash Flow | -3.75M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | -5,783.60% |
| Pretax Margin | -5,981.44% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Alzai Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -20.57% |
| FCF Yield | -18.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Alzai Health has an Altman Z-Score of 9.02 and a Piotroski F-Score of 1.
| Altman Z-Score | 9.02 |
| Piotroski F-Score | 1 |